HHS IG Calls On Drug Makers To Heed Marketing Laws After Report On Rampant Inappropriate Use Of Atypical Antipsychotics In Medicare
This article was originally published in The Pink Sheet Daily
HHS Inspector General finds 88% of Medicare claims for atypical antipsychotic drugs for elderly nursing home residents were used in patients with dementia, despite strict warnings in product labeling.
You may also be interested in...
Sample program focuses only on inpatient use and in hospitals that do not accept Prescription Drug Marketing Act-compliant trial units. By improving adherence, program could lower federal health care costs over time, Office of Inspector General suggests.
A program launched in 2012, the National Partnership to Improve Dementia Care, is on its way to meeting goals of lowering the use of antipsychotic drugs in nursing homes by 15%, with 11 states already hitting that target.
CMS’ proposal to reduce overprescribing in nursing homes draws cautiously favorable response from national pharmacist group, but long-term care pharmacy firm Omnicare argues the agency has not provided adequate justification for its plan.